Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

Clinical trial NCT07131163 · RECRUITING

Trial details

NCT number: NCT07131163
Sponsor: Sheba Medical Center
Status: RECRUITING
Study type: OBSERVATIONAL

Stage II-III Non-small Cell Lung Cancer

Start date: 2024-07-16
Primary completion: 2025-12-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.